Articulate Biosciences
Benjamin Cooper is an accomplished expert in biomaterials and medical device development, serving as CEO and Co-Founder of Ortholevo since 2020, where efforts focus on developing innovative treatments for fibrotic diseases. Additionally, Benjamin has led Articulate Biosciences as CEO and Director of R&D since 2016, commercializing a gel treatment for osteoarthritis, while also providing consultancy in medical device development since 2017. Previous experience includes a postdoctoral fellowship at Grinstaff & Snyder labs and graduate research at Boston University, focusing on cartilage biomechanics and biomaterials chemistry, leading to a PhD in Biomaterials Chemistry. Benjamin holds a BS in Chemistry and Biology from Brandeis University, contributing a solid foundation to a distinguished career in research and development.
This person is not in any teams